AI & Clinical Research

Objectives of the group

To contribute to the attractiveness of France for the realization of Clinical Research (CR) on its territory:

Map the uses of AI in clinical research for each of our professions, as well as the associated tools
Accelerate the development and adoption of AI in our businesses
Ensure the ethics and safety of AI in clinical research
Represent the interests of clinical research companies in discussions on AI in health

Actions

To do this, we will answer these questions as technological advances and uses occur:

What solutions exist for a given profession? How effective are these tools?
What can we increase: productivity, quality, relevance…?
Is this legal? What are the responsibilities?
Is it risky, particularly in terms of confidentiality or intellectual property?
What are the obstacles in practice (internal and external)?

Functioning

The group meets every 4 to 6 weeks by teleconference.

Group Members

Sami Ben Abdallah | BluePharm
Nesrine Benyahia | DrData
Véronique Chapalain | ICTA
Eve Dupas | KYomed INNOV
David Gibon | AQUILAB
Margaux Gouysse | Heva
Flore Jacoud | PELyon
Delphine Ladarré | Clin’S MD
Daniel Laune | KYomed INNOV
Marie Laurent | Heva
Stéphanie Le Goaller | Biotrial
Pierre Le Guellec | YEC’ HED MAT
Sébastien Leuillet | Biofortis (co-animateur du groupe de travail)
Matthieu Marchand | VCLS
Flavien Roux | RCTs
Hervé Servy | Sanoïa (co-animateur du groupe de travail)
Paskëll Stephan-Sieffert | Euraxi
Vincent Susplugas | Collective Thinking

Contact : groupe-ia-rc@afcros.com

Attractiveness

Acting with and with all stakeholders to make France an attractive country for Clinical Research

Medical devices

French expertise on the clinical evaluation of medical devices

Clinical Research Professions

Promote clinical research careers among students and professionals

Real world data

French expertise on real life primary and secondary data